PFA 100 Evaluation and Reference Interval HOACNY

Recruiting in Palo Alto (17 mi)

Overseen by Theresa O'Sullivan, BS,MLT(ASCP)

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 4

Waitlist Available

Sponsor: Hematology Oncology Associates of Central New York

No Placebo Group

Prior Safety Data

Approved in 4 Jurisdictions

Trial Summary

What is the purpose of this trial?

The purpose of this research is to evaluate instrument functionality and develop a reference range of normal data by healthy volunteers.

Eligibility Criteria

This clinical trial is open to adults aged 18 or older who can give consent to participate. It's designed for healthy volunteers who want to help establish normal reference ranges for a new medical instrument.

Inclusion Criteria

Able to consent to study

I am 18 years old or older.

Exclusion Criteria

Allergy to ASA or aspirin

I am taking over-the-counter aspirin.

PFA-100 result falls outside of reference interval

Participant Groups

The study is testing the effects of a single dose of Aspirin (325mg) on participants. The goal is to evaluate how well a new medical instrument works and develop normal data ranges based on the responses from these healthy individuals.

Group I: Placebo (non-intervention) Arm Active Control 1 Intervention

Participants who will have PFA 100 testing performed without the ingestion of aspirin.

Group II: Aspirin Arm Active Control 1 Intervention

Participants who will have PFA 100 testing performed after the ingestion of aspirin.

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Hematology Oncology Associates of Central New York East Syracuse, NY

Who Is Running the Clinical Trial?

Hematology Oncology Associates of Central New York Lead Sponsor

References